We all love a good book and on the Outbreak News This Week Radio Show, I spend most of the hour discussing a fantastic new book on infectious diseases, outbreaks, epidemiologic investigations and not...

It is not just a matter of time when the biological terrorism will hit our world with no mercy.  It is also a matter of choice what agent we will be attacked with. There are no right or wrong pathogens...

CSRA Inc. today announced that a plague vaccine being developed by its subsidiary, DynPort Vaccine Company LLC (DVC), was granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA). DVC...

GENETIC ENGINEERING AND BIOTERRORISM “In warfare there are no constant conditions. He, who can modify his tactics in relation to his opponent, will succeed and win. “ Sun Tzu The biological weapons...

Last week, Gaithersburg, MD based biopharmaceutical company, Emergent BioSolutions Inc. announced the signing of a nearly $1 billion contract with the Centers for Disease Control and Prevention (CDC)...

Scientists are gaining an insider’s look behind the notorious infectivity of Francisella tularensis. This bacterium is an equal opportunity pathogen. It causes the disease tularemia in humans, rabbits...

An Ebola vaccine will take the next critical steps in development under a $24.75 million contract through May 2020 between the U.S. Department of Health and Human Services’ Office of the Assistant...

Professor at Laboure College in Milton, MA and biodefense and bioterrorism researcher, Lawrence Roberge PhD joined me on the Outbreak News This Week Radio Show to discuss a myriad of topics related...

An anthrax vaccine that may be effective in as few as two doses is moving forward in development with the assistance of the U.S. Department of Health and Human Services’ (HHS) Office of the Assistant...

The first potential antidote to treat the life-threatening effects of chlorine inhalation, a potential terrorism threat, will advance in development under a contract between the U.S. Department of Health...